North Rhine-Westphalia is funding AI-assisted cancer research in Bonn with 25 million euros.

University Hospital Bonn, the University of Bonn and the Lamarr Institute are building a joint infrastructure for AI-assisted drug development with 25 million euros in state funding. The site is part of the 200 million euro AI4CancerCure.NRW network involving seven university hospitals and TU Dortmund.

The state of North Rhine-Westphalia is providing 25 million euros to build AI infrastructure in Bonn. University Hospital Bonn, the University of Bonn and the Lamarr Institute plan to design new cancer drugs on computers first and then produce, analyze and test them in the lab. The site is part of the new AI4CancerCure.NRW research network, for which the state is providing 200 million euros in total and which brings together all seven university hospitals in the state along with TU Dortmund.

Bonn takes on a central role: antibodies, miniproteins, peptides and small molecules are meant to be designed with AI methods first and then synthesized and tested experimentally on site for their effect against cancer cells. According to the participating institutes this creates a closed loop of design, experimentation and optimization that tightly links computational design with lab testing. For research partners and suppliers of lab equipment and computing capacity, the funding provides multi-year planning certainty.

What remains open is how quickly the computer-designed drug candidates will turn into drugs usable in clinical practice. The funding covers computing and lab infrastructure, not the later clinical trials. How long the path from an initial design idea to an approved drug will take cannot yet be read from the current announcement.

This story was produced automatically from the source named above and checked by software before publication. The image is symbolic and shows neither the event nor a real person. How this paper is made